Autonomix medical, inc. receives ethics committee authorization for proof-of-concept human clinical study evaluating proprietary ablation technology for treatment of pancreatic cancer pain

First study ever to evaluate radiofrequency (rf) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer

AMIX Ratings Summary

AMIX Quant Ranking